The name of the issuer is NewGenIvf Group Limited., a British Virgin Islands company (the “Issuer”).
Item 1(b) | Address of Issuer’s Principal Executive Offices: |
36/39-36/40, 13th Floor, PS Tower, Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-district, Watthana District, Bangkok 10110, Thailand
Item 2(a) | Name of Person Filing: |
White Lion Capital, LLC
Item 2(b) | Address or Principal Business Office or, if none, Residence: |
17631 Ventura Blvd., Suite 1008, Encino, CA 91316
Nevada
Item 2(d) | Title of Class of Securities: |
Class A ordinary shares, no par value per share, of the Issuer
G0544E105
Item 3 | If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
The information contained in rows 5 through and including row 11 on the cover page of this Schedule 13G, including the footnotes thereto, is incorporated by reference in this Item 4.
Item 5 | Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐
Item 6 | Ownership of More than Five Percent on Behalf of Another Person. |
Not applicable.
Item 7 | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not applicable.